Does interferon-a exert an anti-leukemic effect by enhancing cell mediated immunity in chronic myeloid leukemia?
Muretto
P
P
Tomassoni
S
S
Staccioli
M P
MP
Tabellini
L
L
D'Adamo
F
F
Delfini
C
C
D000328:Adult; D000970:Antineoplastic Agents / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D016898:Interferon-alpha / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000276:immunology*; D008875:Middle Aged; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D000970:Antineoplastic Agents; D016898:Interferon-alpha